Tenaya Therapeutics Announces Pricing of Public Offering
Tenaya Therapeutics aims to fund clinical development of gene therapies TN-201 and TN-401 with $60 million raised from sale of 50 million units at $1.20 each.
6 Articles
6 Articles
Tenaya Stock Drops After Announcing $60M Equity Offering - Tenaya Therapeutics (NASDAQ:TNYA)
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stock is trading lower on Friday, with a session volume of 42.39 million compared to the average volume of 3.51 million as per data from Benzinga Pro. • Tenaya Therapeutics stock is feeling bearish pressure. What’s pressuring TNYA stock? On Thursday, Tenaya Therapeutics priced its underwritten public offering of 50 million units at $1.20 per unit for gross proceeds of $60 million. Each unit consists of on…
Tenaya Therapeutics Announces Pricing of Public Offering
SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced…
Tenaya Stock Plunges After $60 Million Equity Offering
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) stock is trading lower on Friday, with a session volume of 42.39 million compared to the average volume of 3.51 million as per data from Benzinga Pro. • Tenaya Therapeutics stock is feeling bearish pressure. What’s pressuring TNYA stock? On Thursday, Tenaya…
Coverage Details
Bias Distribution
- 75% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium




